UNSPSC 51182020: Bolandiol

This classification denotes an anabolic steroid with the molecular formula C18H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49SD6G16U5, chemically known as 3.beta.,17.beta.-dihydroxyestr-4-ene but generally known as bolandiol, which bears US NIH Compound Identifier 70691434. European Medicines Agency schedules bolandiol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05866MIG. Most nations schedule bolandiol under HS 29061900 and SITC 51231.

As of Q4 2014, BOLANDIOL remains the US FDA Preferred Term for this commodity. SMILES: CCC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4OC(=O)CC)C.

UNSPSC 51182020 Bolandiol is a Commodity code identifying a pharmaceutical active ingredient with minimal recent state and local procurement activity. The source provides no recent opportunities, issuing bodies, geographic distribution, or concrete examples of state or local solicitation under this code.

State and local governments do not appear to be actively procuring bolandiol through posted RFP, RFQ, IFB, or ITT notices at this time. Without evidence of current buying activity, this code does not present an actionable pursuit opportunity in the state and local market.